Timing for evaluation

Jack C. Hou, Philippe E. Zimmern

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The timing of evaluation in patients with an overactive bladder (OAB) remains elusive. With the advent of more numerous drug treatments and formulations for OAB symptoms and marketing campaigns to a broader public, the trend has been to involve primary care physicians in the early prescription of these treatments, often times with limited evaluation and a heavy reliance on symptomatology and degree of bothersomeness to initiate therapy. Once this initial approached failed because of drug side-effects, limited clinical response, and/or cost issues, a referral to a specialist is sometimes considered. Therefore, the ease of drug prescription has undoubtedly affected the timing of evaluation, and delayed it for the most part. Recognizing patients who could benefit from a specialist evaluation is important to confirm the OAB diagnosis and provide a more targeted management. Data on timing of evaluation is sparse as this field is now emerging and has not been very well studied. This review provides directions on timing of evaluation, with a reminder that OAB symptoms can mask a variety of other diagnoses requiring specific therapies.

Original languageEnglish (US)
Title of host publicationOveractive Bladder: Practical Management
PublisherWiley Blackwell
Pages23-28
Number of pages6
ISBN (Print)9781118640562, 9781118640616
DOIs
StatePublished - May 1 2015

Fingerprint

Overactive Urinary Bladder
Drug Prescriptions
Drug Compounding
Primary Care Physicians
Therapeutics
Masks
Marketing
Drug-Related Side Effects and Adverse Reactions
Prescriptions
Referral and Consultation
Costs and Cost Analysis

Keywords

  • And OAB
  • Evaluation
  • Overactive bladder
  • Timing
  • Urgency
  • Urinary frequency

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hou, J. C., & Zimmern, P. E. (2015). Timing for evaluation. In Overactive Bladder: Practical Management (pp. 23-28). Wiley Blackwell. https://doi.org/10.1002/9781118640562.ch3

Timing for evaluation. / Hou, Jack C.; Zimmern, Philippe E.

Overactive Bladder: Practical Management. Wiley Blackwell, 2015. p. 23-28.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hou, JC & Zimmern, PE 2015, Timing for evaluation. in Overactive Bladder: Practical Management. Wiley Blackwell, pp. 23-28. https://doi.org/10.1002/9781118640562.ch3
Hou JC, Zimmern PE. Timing for evaluation. In Overactive Bladder: Practical Management. Wiley Blackwell. 2015. p. 23-28 https://doi.org/10.1002/9781118640562.ch3
Hou, Jack C. ; Zimmern, Philippe E. / Timing for evaluation. Overactive Bladder: Practical Management. Wiley Blackwell, 2015. pp. 23-28
@inbook{384b462f4e714b8191bae04d7b67a264,
title = "Timing for evaluation",
abstract = "The timing of evaluation in patients with an overactive bladder (OAB) remains elusive. With the advent of more numerous drug treatments and formulations for OAB symptoms and marketing campaigns to a broader public, the trend has been to involve primary care physicians in the early prescription of these treatments, often times with limited evaluation and a heavy reliance on symptomatology and degree of bothersomeness to initiate therapy. Once this initial approached failed because of drug side-effects, limited clinical response, and/or cost issues, a referral to a specialist is sometimes considered. Therefore, the ease of drug prescription has undoubtedly affected the timing of evaluation, and delayed it for the most part. Recognizing patients who could benefit from a specialist evaluation is important to confirm the OAB diagnosis and provide a more targeted management. Data on timing of evaluation is sparse as this field is now emerging and has not been very well studied. This review provides directions on timing of evaluation, with a reminder that OAB symptoms can mask a variety of other diagnoses requiring specific therapies.",
keywords = "And OAB, Evaluation, Overactive bladder, Timing, Urgency, Urinary frequency",
author = "Hou, {Jack C.} and Zimmern, {Philippe E.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1002/9781118640562.ch3",
language = "English (US)",
isbn = "9781118640562",
pages = "23--28",
booktitle = "Overactive Bladder: Practical Management",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Timing for evaluation

AU - Hou, Jack C.

AU - Zimmern, Philippe E.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The timing of evaluation in patients with an overactive bladder (OAB) remains elusive. With the advent of more numerous drug treatments and formulations for OAB symptoms and marketing campaigns to a broader public, the trend has been to involve primary care physicians in the early prescription of these treatments, often times with limited evaluation and a heavy reliance on symptomatology and degree of bothersomeness to initiate therapy. Once this initial approached failed because of drug side-effects, limited clinical response, and/or cost issues, a referral to a specialist is sometimes considered. Therefore, the ease of drug prescription has undoubtedly affected the timing of evaluation, and delayed it for the most part. Recognizing patients who could benefit from a specialist evaluation is important to confirm the OAB diagnosis and provide a more targeted management. Data on timing of evaluation is sparse as this field is now emerging and has not been very well studied. This review provides directions on timing of evaluation, with a reminder that OAB symptoms can mask a variety of other diagnoses requiring specific therapies.

AB - The timing of evaluation in patients with an overactive bladder (OAB) remains elusive. With the advent of more numerous drug treatments and formulations for OAB symptoms and marketing campaigns to a broader public, the trend has been to involve primary care physicians in the early prescription of these treatments, often times with limited evaluation and a heavy reliance on symptomatology and degree of bothersomeness to initiate therapy. Once this initial approached failed because of drug side-effects, limited clinical response, and/or cost issues, a referral to a specialist is sometimes considered. Therefore, the ease of drug prescription has undoubtedly affected the timing of evaluation, and delayed it for the most part. Recognizing patients who could benefit from a specialist evaluation is important to confirm the OAB diagnosis and provide a more targeted management. Data on timing of evaluation is sparse as this field is now emerging and has not been very well studied. This review provides directions on timing of evaluation, with a reminder that OAB symptoms can mask a variety of other diagnoses requiring specific therapies.

KW - And OAB

KW - Evaluation

KW - Overactive bladder

KW - Timing

KW - Urgency

KW - Urinary frequency

UR - http://www.scopus.com/inward/record.url?scp=84946713064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946713064&partnerID=8YFLogxK

U2 - 10.1002/9781118640562.ch3

DO - 10.1002/9781118640562.ch3

M3 - Chapter

AN - SCOPUS:84946713064

SN - 9781118640562

SN - 9781118640616

SP - 23

EP - 28

BT - Overactive Bladder: Practical Management

PB - Wiley Blackwell

ER -